3rd International Conference on Therapies for Viral Hepatitis.
This meeting was attended by several hundred delegates and covered, in lecture and poster presentations, recent developments in basic, applied and clinical research as they concern antiviral drug development for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Below are summaries of presentations that are relevant to the development of antiviral drug resistance. Copyright 2000 Harcourt Publishers Ltd.
King
Robert W.
RW
Virology Group, DuPont Pharmaceuticals Co., Wilmington, DE, USA